Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights

Ralf Weigel1, Ireen Makwiza, Jean Nyirenda

  • 1The Lighthouse Trust at Kamuzu Central Hospital, PO Box 106, Lilongwe, Malawi. r_weigel@lighthouse.org.mw

BMC Pediatrics
|July 16, 2009
PubMed

Insights

High adherence to anti-retroviral treatment (ART) in children is achievable in resource-poor settings with caregiver support. Addressing challenges like cost and clinic wait times is crucial for successful pediatric HIV management.

Area of Science:

  • Pediatric infectious diseases
  • Global health
  • HIV/AIDS research

Background:

  • Anti-retroviral treatment (ART) adherence is crucial for pediatric HIV management.
  • Resource-poor settings face challenges in supporting adherence for children on ART.
  • Formative research is needed to understand caregiver perspectives on pediatric ART adherence.

Purpose of the Study:

  • To assess adherence in children receiving ART in Malawi.
  • To explore caregiver knowledge, perceptions, and attitudes towards pediatric ART adherence.
  • To identify challenges and opportunities for improving pediatric ART adherence.

Main Methods:

  • Prospective follow-up of 47 children initiating ART (age 8 months to 12 years).
  • Quantitative adherence assessment via caregiver reports of missed doses (monthly).
  • Qualitative data from focus groups and critical incident narratives with caregivers.

Main Results:

  • 72% of children had no missed doses reported by caregivers.
  • 82% of clinic visits were attended on time or within one week.
  • Caregivers were motivated but faced challenges including cost, transport, wait times, and stock-outs.

Conclusions:

  • Holistic support strategies are needed for children, caregivers, and health workers in fragile health systems.
  • Cost-free, less complex pediatric ART regimens are recommended.
  • Culturally appropriate tools are essential to enhance pediatric ART adherence.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...